about
Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviewsRegular long-term red blood cell transfusions for managing chronic chest complications in sickle cell diseaseRegular long-term red blood cell transfusions for managing chronic chest complications in sickle cell diseaseBlood transfusions for treating acute chest syndrome in people with sickle cell diseaseGuideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology.Efficacy and Safety of Manual Partial Red Cell Exchange in the Management of Severe Complications of Sickle Cell Disease in a Developing Country.Iron overload in sickle cell disease.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Erythrocytapheresis: Do Not Forget a Useful Therapy!Study of Twenty One Cases of Red Cell Exchange in a Tertiary Care Hospital in Southern IndiaTransfusion practices in the management of sickle cell disease: a survey of Florida hematologists/oncologists.Current management of sickle cell anemia.Effect of automated red cell exchanges on oxygen saturation on-air, blood parameters and length of hospitalization in sickle cell disease patients with acute chest syndromeRed blood cell and leukocyte alloimmunization in patients awaiting kidney transplantation.Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis.Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.Sickle cell trait-associated deaths: a case series with a review of the literature.Out with the bad and in with the good; red cell exchange, white cell reduction, and platelet reduction.Chemotherapeutic treatment of priapism in metastatic rectal cancer.Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance.How I treat priapism.Blood transfusion services for patients with sickle cell disease in Nigeria.Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.Optimal Manual Exchange Transfusion Protocol for Sickle Cell Disease: A Retrospective Comparison of Two Comprehensive Care Centers in the United Kingdom and Canada.A pilot study of manual chronic partial exchange transfusion in children with sickle disease.Automated red cell exchange: a simplified formula for how many red cell units to exchange and validity of haemoglobin S levels measured one to two hours later.Intrahepatic cholestasis in sickle cell disease: a case report.Inositol hexaphosphate-loaded red blood cells prevent in vitro sickling.How do I transfuse patients with sickle cell disease?Exchange versus simple transfusion for acute chest syndrome in sickle cell anemia adults.The evaluation of a new apheresis device for automated red blood cell exchange procedures in patients with sickle cell disease.Sickle cell trait as a contributory cause of death in natural disease.Red cell exchange transfusion halts progressive proliferative sickle cell retinopathy in a teenaged patient with hemoglobin SC disease.Red cells exchanges in sickle cells disease lead to a selective reduction of erythrocytes-derived blood microparticles.Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease.Rinseback during red blood cell exchange with COBE Spectra does not affect fraction of cells remaining or post-exchange hematocrit.
P2860
Q24186232-8B275122-F915-43D6-8F14-C6C4C16D290CQ24234406-B349B994-429D-4E79-8DB6-B80F8534E611Q24240205-5AEE9554-D35A-4871-B5DD-3A4DDE63D709Q24240450-30746189-2B64-4218-9815-04CF8F2EF237Q33165774-C0743724-5A57-4F01-B789-56DFCC8E2C26Q33726299-958B44FE-7CBA-45D5-896D-0783D8F074F5Q33861129-0815F6CA-FE62-48D8-ABC4-9B703224F82FQ34122035-B4D3CF8D-3AB5-4756-B90D-C8CA79FA14AFQ34870383-8B02CB88-8C1D-4EDC-BAF1-66B1EEAADE80Q36082570-9EECCF50-23FC-482A-ABD3-20C6A9050D73Q36490354-7C99224E-0CDA-4325-BC16-DC6F327324B3Q37040238-F9E5A29C-C7D7-4EF4-96E7-882643477CF6Q37045665-5D582B78-375B-43FB-89B7-645D440F414BQ37057020-D5CBAF42-DC15-43D4-A315-D1E5F8C866D7Q37344320-39E6ABD2-C658-47B1-A310-1BBB55FF659AQ37836673-7AD49014-6D4D-4968-AD0F-A7E1941F4D1CQ37863697-124835FC-20F8-446E-991B-9C5E84E7B883Q38211763-6A439C12-63FA-4E09-A1C1-0E21CB1FD58FQ38303436-E91541D7-8645-450A-9A55-ED3C0FF012D2Q39007268-1E496759-7FE1-4A54-B87C-917C9BDD9666Q39025090-E863E6BC-C405-4BD9-B4D8-6D2532391064Q40836280-7D744B82-5FF3-474A-8D15-792C242CE5F5Q41576877-AC87E146-B310-46D6-9D97-E0C543D39223Q41638881-817E54BF-EC18-47C0-8678-1AEC93D64884Q42199323-AF6C01D3-CE95-4CE0-87CC-9F9E695E2A88Q42430788-E585C345-F07A-4CD8-9CCC-AB30D8307FD1Q42705093-BF07C06C-B5E9-4903-9A1B-60009CE853EAQ43067641-D834C5DC-BF1B-4C18-AD88-8B1E72FD4D16Q43429355-E741F8C3-5FDC-41AB-9A2A-9806F6DD6389Q46077219-0180E1FF-0743-453C-A794-D036B4BB8DFEQ46415619-14EE0108-C406-4B11-AF40-6386AF687D45Q50452312-BBA0C96E-AE3F-4B34-B481-0DF394889C1BQ50452826-EC4206AF-135E-4CA5-9378-3A1449171611Q50524895-30EEF720-2267-4BAD-AD72-C378964BAC27Q50528247-408A1C4C-1E12-4098-B2AA-123F9BAFA848Q50570379-853598F6-DC15-43F6-B009-C8069116D0AA
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Red cell exchange in sickle cell disease.
@ast
Red cell exchange in sickle cell disease.
@en
type
label
Red cell exchange in sickle cell disease.
@ast
Red cell exchange in sickle cell disease.
@en
prefLabel
Red cell exchange in sickle cell disease.
@ast
Red cell exchange in sickle cell disease.
@en
P1476
Red cell exchange in sickle cell disease.
@en
P2093
Paul S Swerdlow
P356
10.1182/ASHEDUCATION-2006.1.48
P577
2006-01-01T00:00:00Z